JPH01141600A - Production of optically active 3-hydroxypyrrolidine derivative - Google Patents
Production of optically active 3-hydroxypyrrolidine derivativeInfo
- Publication number
- JPH01141600A JPH01141600A JP30105287A JP30105287A JPH01141600A JP H01141600 A JPH01141600 A JP H01141600A JP 30105287 A JP30105287 A JP 30105287A JP 30105287 A JP30105287 A JP 30105287A JP H01141600 A JPH01141600 A JP H01141600A
- Authority
- JP
- Japan
- Prior art keywords
- benzyl
- optically active
- acyloxypyrrolidine
- microorganism
- hydroxypyrrolidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 14
- JHHZLHWJQPUNKB-UHFFFAOYSA-N pyrrolidin-3-ol Chemical class OC1CCNC1 JHHZLHWJQPUNKB-UHFFFAOYSA-N 0.000 title abstract description 3
- 102000004190 Enzymes Human genes 0.000 claims abstract description 34
- 108090000790 Enzymes Proteins 0.000 claims abstract description 34
- 244000005700 microbiome Species 0.000 claims abstract description 33
- YQMXOIAIYXXXEE-UHFFFAOYSA-N 1-benzylpyrrolidin-3-ol Chemical compound C1C(O)CCN1CC1=CC=CC=C1 YQMXOIAIYXXXEE-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000000203 mixture Substances 0.000 claims abstract description 22
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- 230000003301 hydrolyzing effect Effects 0.000 claims abstract description 6
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 5
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 5
- 241000235395 Mucor Species 0.000 claims abstract description 4
- 241000589516 Pseudomonas Species 0.000 claims abstract description 4
- 230000003287 optical effect Effects 0.000 claims description 23
- 239000002904 solvent Substances 0.000 claims description 13
- 230000000694 effects Effects 0.000 claims description 11
- 108090000371 Esterases Proteins 0.000 claims description 10
- 230000000707 stereoselective effect Effects 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 102000004882 Lipase Human genes 0.000 claims description 6
- 239000004367 Lipase Substances 0.000 claims description 6
- 108090001060 Lipase Proteins 0.000 claims description 6
- 241000235527 Rhizopus Species 0.000 claims description 6
- 235000019421 lipase Nutrition 0.000 claims description 6
- 239000003463 adsorbent Substances 0.000 claims description 4
- 241000588986 Alcaligenes Species 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- YQMXOIAIYXXXEE-NSHDSACASA-N (3s)-1-benzylpyrrolidin-3-ol Chemical compound C1[C@@H](O)CCN1CC1=CC=CC=C1 YQMXOIAIYXXXEE-NSHDSACASA-N 0.000 claims description 2
- 230000002209 hydrophobic effect Effects 0.000 claims description 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 3
- 238000004440 column chromatography Methods 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 22
- 239000000243 solution Substances 0.000 description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- -1 fatty acid halide Chemical class 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000000034 method Methods 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000006460 hydrolysis reaction Methods 0.000 description 8
- 238000004821 distillation Methods 0.000 description 7
- 239000008363 phosphate buffer Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- YQMXOIAIYXXXEE-LLVKDONJSA-N (3r)-1-benzylpyrrolidin-3-ol Chemical compound C1[C@H](O)CCN1CC1=CC=CC=C1 YQMXOIAIYXXXEE-LLVKDONJSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- FFOZMTLALDUGCN-UHFFFAOYSA-N (1-benzylpyrrolidin-3-yl) butanoate Chemical compound C1C(OC(=O)CCC)CCN1CC1=CC=CC=C1 FFOZMTLALDUGCN-UHFFFAOYSA-N 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 229920001429 chelating resin Polymers 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 3
- 102000043296 Lipoprotein lipases Human genes 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- SRRYTFQCJKSUDO-UHFFFAOYSA-N (1-benzylpyrrolidin-3-yl) hexanoate Chemical compound C1C(OC(=O)CCCCC)CCN1CC1=CC=CC=C1 SRRYTFQCJKSUDO-UHFFFAOYSA-N 0.000 description 2
- GUPXYSSGJWIURR-UHFFFAOYSA-N 3-octoxypropane-1,2-diol Chemical compound CCCCCCCCOCC(O)CO GUPXYSSGJWIURR-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 241000235400 Phycomyces Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 229940116298 l- malic acid Drugs 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000009629 microbiological culture Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- JHHZLHWJQPUNKB-BYPYZUCNSA-N (3s)-pyrrolidin-3-ol Chemical compound O[C@H]1CCNC1 JHHZLHWJQPUNKB-BYPYZUCNSA-N 0.000 description 1
- IWYDHOAUDWTVEP-SSDOTTSWSA-N (R)-mandelic acid Chemical compound OC(=O)[C@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-SSDOTTSWSA-N 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N 4-(hydroxymethyl)oxolane-2,3,4-triol Chemical compound OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000252867 Cupriavidus metallidurans Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical class OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 101710084373 Lipase 1 Proteins 0.000 description 1
- 102100030659 Lipase member I Human genes 0.000 description 1
- 241000498617 Mucor javanicus Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000134731 Phycomyces nitens Species 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical group CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 241000952054 Rhizopus sp. Species 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 238000005574 benzylation reaction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000010410 calcium alginate Nutrition 0.000 description 1
- 239000000648 calcium alginate Substances 0.000 description 1
- 229960002681 calcium alginate Drugs 0.000 description 1
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000000911 decarboxylating effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- KDCIHNCMPUBDKT-UHFFFAOYSA-N hexane;propan-2-one Chemical compound CC(C)=O.CCCCCC KDCIHNCMPUBDKT-UHFFFAOYSA-N 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Substances [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 150000003235 pyrrolidines Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000007070 tosylation reaction Methods 0.000 description 1
- PMMYEEVYMWASQN-IMJSIDKUSA-N trans-4-Hydroxy-L-proline Natural products O[C@@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-IMJSIDKUSA-N 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
(式中、Xは水素あるいは炭素数1〜17の置換又は未
置換アルキル基、アルケニル基を示す。)で示される(
R)および(8) −N−ベンジル−3−アシロキシピ
ロリジン混合物を立体選択的に加水分解して、一般式[
1[]
で示される光学活性なN−ベンジル−3−ヒドロキシピ
ロリジンを生成させる立体選択的エステラーゼ活性を有
する微生物あるいは酵素を一般式〔IDで示される(i
t)および(S) −N−ベンジル−3−アシロキシピ
ロリジン混合物に作用させ、光学活性なN−ベンジル−
3−ヒドロキシピロリジン[I[]と、これと立体的に
対掌な一般式〔白(式中、Xは前記と同じ)で示される
光学活性なN−ベンジル−3−アシロキシピロリジンと
に光学分割し、夫々の光学活性化合物を分離採取するこ
とを特徴とする光学活性なN−ベンジル−3−ヒドロキ
シピロリジン及びその対掌体の光学活性N−ベンジル−
3−アシロキシピロリジンの製造法に関する。Detailed Description of the Invention (Industrial Application Field) (In the formula, X represents hydrogen or a substituted or unsubstituted alkyl group or alkenyl group having 1 to 17 carbon atoms.)
R) and (8) -N-benzyl-3-acyloxypyrrolidine mixture is stereoselectively hydrolyzed to form the general formula [
1 [] A microorganism or enzyme having stereoselective esterase activity that produces optically active N-benzyl-3-hydroxypyrrolidine represented by the general formula [ID (i
t) and (S) -N-benzyl-3-acyloxypyrrolidine mixture to form optically active N-benzyl-
3-Hydroxypyrrolidine [I[] and optically active N-benzyl-3-acyloxypyrrolidine represented by the general formula [white (in the formula, X is the same as above)] which is sterically opposite to this, Optically active N-benzyl-3-hydroxypyrrolidine and its enantiomer optically active N-benzyl-3-hydroxypyrrolidine, which is characterized by dividing and separating and collecting each optically active compound.
The present invention relates to a method for producing 3-acyloxypyrrolidine.
本発明によって製造される光学活性なN−ベンジル−3
−ヒドロキシピロリジン及びN−ベンジル−3−アシロ
キシピロリジンは医薬、農薬等の有用な合成中間体であ
る。Optically active N-benzyl-3 produced by the present invention
-Hydroxypyrrolidine and N-benzyl-3-acyloxypyrrolidine are useful synthetic intermediates for pharmaceuticals, agricultural chemicals, and the like.
(従来の技術と問題点)
光学活性(S) −N−ベンジル−3−ヒドロキシピロ
リジンの製法に関しては、L−リンゴ酸を原料として合
成する方法(特開昭6l−63652)が知られている
が、一部ラセミ化するため、これを更にD−マンデル酸
にて光学分割を行ない光学純度を向上させる必要がある
。またN−ベンジル−8−ピロリンを不斉還元剤として
(→−ジイソピイノカンフエイルボランを用いて還元す
る方法が知られている〔ジャーナル・オブ・アメリカン
・ケミカル・ソサイアテイ−(J 、 Am 、 Oh
em、 Soc、)、ios、2049.1986]。(Prior art and problems) Regarding the production method of optically active (S) -N-benzyl-3-hydroxypyrrolidine, a method of synthesizing L-malic acid as a raw material (Japanese Patent Application Laid-Open No. 61-63652) is known. However, since it is partially racemized, it is necessary to further perform optical resolution with D-mandelic acid to improve optical purity. In addition, a method of reducing N-benzyl-8-pyrroline using an asymmetric reducing agent (→-diisopiinocampheylborane) is known [Journal of American Chemical Society (J, Am , Oh
em, Soc, ), ios, 2049.1986].
また、N位にベンジル基のない(S) −3−ヒドロキ
シピロリジンについてはL−グルタミン酸から導く方法
(シンセテイク・コミュニケーション、16.1815
.1986)があり、逆の(R)体についてはトランス
−4−ヒドロキシ−L−プロリンを脱炭酸して得る方法
(特開昭6O−23328)が知られており、これらを
ベンジル化して合成することも可能である。しかし、い
ずれの方法も工程が長かったり、特殊な試剤を必要とす
る等で経済的な工業的製法とは考え難い。In addition, for (S)-3-hydroxypyrrolidine that does not have a benzyl group at the N-position, a method of deriving it from L-glutamic acid (Synthetake Communication, 16.1815
.. 1986), and the reverse (R) form is obtained by decarboxylating trans-4-hydroxy-L-proline (Japanese Patent Application Laid-Open No. 6O-23328), which is synthesized by benzylation. It is also possible. However, these methods are difficult to consider as economical industrial production methods because they require long steps and special reagents.
本発明は、医薬品等の合成原料として有用な式[IDで
示される光学活性N−ベンジル−3−ヒドロキシピロリ
ジン及び一般式〔1′〕で示される光学活性N−ベンジ
ル−3−アシロキシピロリジンを化学的に容易に合成し
うる(R)および(S) −N −ベンジル−3−アシ
ロキシピロリジン混合物を微生物あるいは酵素により立
体選択的に加水分解することにより光学分割することで
経済的に生産することを目的としたものである。The present invention provides optically active N-benzyl-3-hydroxypyrrolidine represented by the formula [ID] and optically active N-benzyl-3-acyloxypyrrolidine represented by the general formula [1'], which are useful as synthetic raw materials for pharmaceuticals, etc. It is economically produced by optical resolution by stereoselectively hydrolyzing a mixture of (R) and (S) -N-benzyl-3-acyloxypyrrolidine, which can be easily chemically synthesized, using microorganisms or enzymes. It is intended for this purpose.
(問題点を解決するための手段と作用)先に本発明者、
らは、(R)体と(8)体の等量混合物であるラセミ体
の(R8)−N−ベンジル−3−アシロキシピロリジン
[Il]は、これまでに報告されたことのない新規化合
物であるが、このものは安価なり L−リンゴ酸等から
容易に合成しうる(R5)−N−ベンジル−3−ヒドロ
キシピロリジンと脂肪酸ハライド等と反応させることで
容易に合成しうる事を見い出し、特許出願した。次に本
発明者らは、この新規化合物である(R)および(S)
−N−ベンジル−3−アシロキシピロリジン混合物[
1〕を微生物あるいは酵素により不斉加水分解をして光
学分割することを考え検討を行った。(Means and effects for solving the problem) First, the inventor,
reported that racemic (R8)-N-benzyl-3-acyloxypyrrolidine [Il], which is a mixture of equal amounts of the (R) and (8) isomers, is a novel compound that has never been reported before. However, we discovered that this product is inexpensive and can be easily synthesized by reacting (R5)-N-benzyl-3-hydroxypyrrolidine, which can be easily synthesized from L-malic acid, with a fatty acid halide, etc. A patent application was filed. Next, the present inventors discovered that this new compound (R) and (S)
-N-benzyl-3-acyloxypyrrolidine mixture [
1] was considered and investigated by asymmetric hydrolysis using microorganisms or enzymes for optical resolution.
その結果、化合物〔IDを立体選択的に加水分解し、光
学活性な化合物[■〕を生成させうる微生物および酵素
の存在を見い出し、該反応後、簡単な分離操作により光
学活性なN−ベンジル−3−ヒドロキシピロリジン〔■
〕と立体的に対掌な光学活性N−ベンジル−3−アシロ
キシピロリジン〔I′〕とを採取しうる事を見い出した
。また光学活性のN−ベンジル−3−アシロキシピロリ
ジン[1’]fi、更にアルカリ加水分解あるいは本発
明で見い出した微生物や酵素あるいは立体選択性のない
リバーゼ等を用いて加水分解することにより立体配置を
保持した光学活性N−ベンジル−3−ヒドロキシピロリ
ジンとすることができ、いずれの立体特異性をもつ微生
物あるいは酵素を用いても(R)体と(8)体のN−ベ
ンジル−3−ヒドロキシピロリジン両対掌体を同時に得
ることができる。As a result, we discovered the existence of microorganisms and enzymes that can stereoselectively hydrolyze the compound [ID] to produce an optically active compound [■]. 3-Hydroxypyrrolidine [■
] and optically active N-benzyl-3-acyloxypyrrolidine [I'], which is sterically antipodal. In addition, optically active N-benzyl-3-acyloxypyrrolidine [1']fi can be further hydrolyzed using alkaline hydrolysis, microorganisms or enzymes discovered in the present invention, or reverse without stereoselectivity to achieve stereoconfiguration. It is possible to obtain optically active N-benzyl-3-hydroxypyrrolidine retaining the (R) and (8) N-benzyl-3-hydroxy pyrrolidines using microorganisms or enzymes with any stereospecificity. Both pyrrolidine enantiomers can be obtained simultaneously.
本製造法の発明により、従来法と比べ経済的に光学活性
なN−ベンジル−3−ヒドロキシピロリジンおよび光学
活性なN−ベンジル−3−アシロキシピロリジンの各々
の両対掌体の生産が可能となった。The invention of this production method enables the production of both enantiomers of optically active N-benzyl-3-hydroxypyrrolidine and optically active N-benzyl-3-acyloxypyrrolidine more economically than conventional methods. became.
本発明の基質として用いられる一般式[1〕で表わされ
る01)および(S) −N−ベンジル−3−アシロキ
シピロリジンは、(R)体と(8)体の等量混合物であ
るラセミ体でも、(R)体か(8)体のいずれかがより
多く含まれた混合物でも使用しうる。また置換基Xとし
ては、水素あるいは炭素数1〜17個の直鎖あるいは分
岐アルキル基、アルケニル基で無置換のもの、あるいは
ハロゲン等で置換されたものも用いることができる。例
えば、メチル基、エチル基、エチレン基、n−プロピル
基、イソプロピル基、1−プロピレン基、n−ブチル基
、イソブチル基、1−ブチlノン基、n−ペンチル基、
n−ヘキシル基、n−ヘプチル基、n−オクチル基、n
−ノナシル基、n−デシル基。01) and (S)-N-benzyl-3-acyloxypyrrolidine represented by the general formula [1] used as the substrate of the present invention are racemic bodies that are a mixture of equal amounts of the (R) and (8) bodies. However, a mixture containing a larger amount of either the (R) isomer or the (8) isomer may also be used. Further, as the substituent X, hydrogen, a linear or branched alkyl group having 1 to 17 carbon atoms, an alkenyl group, unsubstituted, or substituted with halogen or the like can be used. For example, methyl group, ethyl group, ethylene group, n-propyl group, isopropyl group, 1-propylene group, n-butyl group, isobutyl group, 1-butylonone group, n-pentyl group,
n-hexyl group, n-heptyl group, n-octyl group, n
-nonacyl group, n-decyl group.
n−ウンデシル基、n−ドデシル基、n−トリデシル基
、n−テトラデシル基、n−ペンタデシル基、n−ヘキ
サデシル基、n−ヘプタデシル基。n-undecyl group, n-dodecyl group, n-tridecyl group, n-tetradecyl group, n-pentadecyl group, n-hexadecyl group, n-heptadecyl group.
n−オクタデシル基等の直鎖あるいは分岐状の未置換ア
ルキル基、アルケニル基等、例えばクロロメチル基、ジ
クロロメチル基、トリフロロメチル基、2−クロロエチ
ル基、3−クロロプロピル基。Straight chain or branched unsubstituted alkyl groups such as n-octadecyl group, alkenyl groups, etc., such as chloromethyl group, dichloromethyl group, trifluoromethyl group, 2-chloroethyl group, 3-chloropropyl group.
4−クロロブチル基等のハロゲンロ換された置換アルキ
ル基等が挙げられる。Examples include halogen-substituted alkyl groups such as 4-chlorobutyl group.
化合物El)を立体選択的に加水分解し、光学活性[I
I]を生成させる立体選択的エステラーゼ活性を有する
微生物あるいは酵素は、次の様なスクリーニングを行な
えば容易に見い出すことができる。Compound El) was stereoselectively hydrolyzed to obtain optically active [I
Microorganisms or enzymes that have stereoselective esterase activity that produce [I] can be easily found by conducting the following screening.
例えばその具体的な一例として示すと、微生物の生育可
能な栄養培地10mJを大型試検管に入れ、被試験菌を
植苗後、25〜35℃で1〜3日間振とう培養する。次
に、この培養液に(R8)−N−ベンジル−3−ブチリ
ルオキシピロリジンを2π(W/V) 添加し、更に2
0〜35℃、pHをN aOHでpH5〜7に調整しな
がら1〜3日間反応させる。加水分解の進行は、反応液
を硫酸でpf−L2.0とし2倍量の酢酸エチルで生成
する醋酸を抽出し、これをガスクロマトグラフィー(充
填剤、島津FAL−M6%/シマライト、φ0.3×1
00 cmカラム、温度140℃)にて定量することで
分析できる。各反応液の経時変化をとり、添加基質に対
して、生成する醋酸が約2分の1当壇生成したところで
反応が極端に遅くなる菌株を1次選択する。次に反応ス
ケールを500mJにかえ、前記と同様の培養及び加水
分解を行ない、終了後、ジクロロメタン500m1!で
4回抽出し、減圧下で脱溶剤する。これをシリカゲルカ
ラム(ワコーゲルC−200,250,F)に負荷し、
ヘギサン/酢酸エチル(10/2 )で未反応のN−ベ
ンジル−3−ブチリルオキシピロリジンを溶出する。更
に、酢酸エチルで生成したN−ベンジル−3−ヒドロキ
シピロリジンを溶出する。各両分を濃縮すれば油状の光
学活性N−ベンジル−3−ブチリルオキシピロリジンと
光学活性N−ベンジル−3−ヒドロキシピロリジンが得
られる。For example, as a specific example, 10 mJ of a nutrient medium in which microorganisms can grow is placed in a large test tube, seedlings of the test bacteria are planted, and then cultured with shaking at 25 to 35°C for 1 to 3 days. Next, 2π (W/V) of (R8)-N-benzyl-3-butyryloxypyrrolidine was added to this culture solution, and
The reaction is carried out at 0 to 35°C for 1 to 3 days while adjusting the pH to 5 to 7 with NaOH. To progress the hydrolysis, the reaction solution was adjusted to pf-L2.0 with sulfuric acid, the acetic acid produced was extracted with twice the amount of ethyl acetate, and this was analyzed by gas chromatography (filling material, Shimadzu FAL-M 6%/Simalite, φ0. 3×1
00 cm column, temperature 140°C). The time-dependent changes in each reaction solution are observed, and a strain that exhibits an extremely slow reaction is selected for the first time when about half the amount of acetic acid produced relative to the added substrate is produced. Next, change the reaction scale to 500 mJ, perform the same cultivation and hydrolysis as above, and after completion, use 500 ml of dichloromethane! Extract 4 times and remove solvent under reduced pressure. This was loaded onto a silica gel column (Wakogel C-200, 250, F),
Unreacted N-benzyl-3-butyryloxypyrrolidine was eluted with hegisan/ethyl acetate (10/2). Furthermore, N-benzyl-3-hydroxypyrrolidine produced is eluted with ethyl acetate. By concentrating both components, oily optically active N-benzyl-3-butyryloxypyrrolidine and optically active N-benzyl-3-hydroxypyrrolidine are obtained.
そして、光学活性N−ベンジル−3−ブチリルオキシピ
ロリジンはNaOHで加水分解すれば、光学活性を損う
事なく光学活性のN−ベンジル−3−ヒドロキシピロリ
ジンとなり、これらを蒸留により精製し、比旋光度を測
定すれば、立体選択的エステラーゼ活性を有する微生物
か否か容易に判断できる。各皿起源の酵素のスクリーニ
ングにおいても微生物培養液の代りに、酵素0.5Iを
10m1の0.1 Mリン酸緩衝液に溶解し、同様な方
法で行なう事ができる。この様にN−ベンジル−3−ブ
チリルオキシピロリジンを立体選択的に加水分解しうる
微生物あるいは酵素は前記の様な各14のN−ベンジル
−3−アシロキシピロリジンに対しても同様な立体選択
的加水分解活性を示す。When optically active N-benzyl-3-butyryloxypyrrolidine is hydrolyzed with NaOH, it becomes optically active N-benzyl-3-hydroxypyrrolidine without loss of optical activity, which is purified by distillation and compared to By measuring the optical rotation, it can be easily determined whether the microorganism has stereoselective esterase activity or not. Screening for enzymes originating from each dish can be carried out in the same manner by dissolving 0.5I of the enzyme in 10 ml of 0.1 M phosphate buffer instead of the microbial culture solution. In this way, microorganisms or enzymes that can stereoselectively hydrolyze N-benzyl-3-butyryloxypyrrolidine can also stereoselectively hydrolyze each of the 14 N-benzyl-3-acyloxypyrrolidines mentioned above. Shows hydrolytic activity.
(B、)および(8) −N−ベンジル−3−アシロキ
シピロリジン混合物を立体選択的に加水分解し、(R)
−CIOと(s)−CI’〕を与える立体選択的エステ
ラーゼ活性を有する微生物としては、例えばシュードモ
ナス属、ムコール属、アルカリゲネス属等に属する微生
物があり、更に詳しくはシュードモナス・フルオレッセ
ンス(Pseudomonasf 1uorescen
s ) 1FO3081、シュードモナス−7:Lル
ギノーサ(Pseudomonas aerugi −
nosa) I F 0 3080、ムコール・ジャ
バニクス(Mucor javanicus ) I
FO4569、アルカリゲネス・ユートロフス(Ale
al igenseutrophus) ATCC1
7697などが利用できる。(B, ) and (8) -N-benzyl-3-acyloxypyrrolidine mixtures were stereoselectively hydrolyzed and (R)
-CIO and (s)-CI'] Examples of microorganisms that have stereoselective esterase activity include microorganisms belonging to the genus Pseudomonas, Mucor, and Alcaligenes.
s) 1FO3081, Pseudomonas-7: Pseudomonas aerugi-
nosa) I F 0 3080, Mucor javanicus I
FO4569, Alcaligenes eutrophus (Ale
al igenseutrophus) ATCC1
7697 etc. can be used.
これらの微生物は培養液そのものを用いる事ができるが
、培養液あるいは菌体から酵素を抽出精製して用いるこ
ともできる。また市販酵素を直接用いることもできる。The culture solution itself can be used for these microorganisms, but enzymes can also be extracted and purified from the culture solution or bacterial cells. Also, commercially available enzymes can be used directly.
例えばリポプロティンリパーゼ(LPLアマノ3、シュ
ードモナス属由来、大野製薬味製)、リパーゼM−AP
10 (ムコール属由来、大野製薬味製)、リパーゼ
PL(アルカリゲネス属、名糖産業■製)などがこの目
的に適している。For example, lipoprotein lipase (LPL Amano 3, derived from Pseudomonas genus, manufactured by Ohno Pharmaceutical), lipase M-AP
10 (derived from the genus Mucor, manufactured by Ohno Seiyaku Aji), Lipase PL (derived from the genus Alcaligenes, manufactured by Meito Sangyo ■), and the like are suitable for this purpose.
一方、(R)および(8) −N−ベンジル−3−アシ
ロキシピロリジン混合物を立体選択的に加水分解し、(
8) −Cl]と(R) −C白を与える立体選択的エ
ステラーゼ活性を有する微生物としてはりゾツプス属、
フィコマイセス属等に属する微生物があり、更に詳しく
は、リゾップス・ジャボニカス(Rhizopus j
aponieus) I F O4758、リゾップス
・デレマー(Rhizopus delemer )I
FO4697、フィコマイセス・ニテンス(Phyco
myees n1tens) I F 0 5694、
などが利用できる。On the other hand, a mixture of (R) and (8) -N-benzyl-3-acyloxypyrrolidine was stereoselectively hydrolyzed, and (
8) -Cl] and (R) -C as a microorganism having stereoselective esterase activity that gives white
There are microorganisms belonging to the genus Phycomyces, etc., and more specifically, Rhizopus jabonicus (Rhizopus j.
aponius) I F O4758, Rhizopus delemer (Rhizopus delemer) I
FO4697, Phycomyces nitens (Phyco
myees n1tens) I F 0 5694,
etc. are available.
これらの微生物は培養液そのものを用いる事ができるが
、培養液あるいは菌体から酵素を抽出精製して用いるこ
ともできる。また市販酵素を直接用いることもできる。The culture solution itself can be used for these microorganisms, but enzymes can also be extracted and purified from the culture solution or bacterial cells. Also, commercially available enzymes can be used directly.
例えば、リパーゼI’N(フィコマイセス属由来、和光
純薬■製)、リパーゼ(リゾップス属由来、生化学工業
■製)、リパーゼ「サイケンJ100(リゾップス属由
来、大阪細菌研究所■製)、ニューラーゼ(リゾップス
属由来、天府製薬■製)などがこの目的に適している。For example, Lipase I'N (derived from Phycomyces sp., manufactured by Wako Pure Chemical Industries, Ltd.), Lipase (derived from Rhizops sp., manufactured by Seikagaku Kogyo ■), Lipase "Saiken J100 (derived from Rhizopus sp., manufactured by Osaka Bacteria Research Institute ■), Neurase" (derived from the genus Rhizopus, manufactured by Tenfu Pharmaceutical) are suitable for this purpose.
加水分解反応は、微生物培養液あるいは酵素抽出物又は
酵素の水溶液に基質〔I〕を0.5〜75π(W/V)
濃度の範囲で添加し、温度10〜55℃の範囲で撹拌し
ながら行なう。酵素量は酵素活性に依存するが、通常〔
I〕に対して等量から1000分の1の範囲で行なう。In the hydrolysis reaction, substrate [I] is added to a microbial culture solution, enzyme extract, or enzyme aqueous solution at a rate of 0.5 to 75π (W/V).
Addition is carried out at a concentration range of 10°C to 55°C with stirring. The amount of enzyme depends on the enzyme activity, but usually [
I] in a range from equivalent to 1/1000th.
反応のpllは5.0〜8.5の範囲で行なうが、加水
分解反応中にpHが変化する場合は適当な酸やアルカリ
水溶液で最適のpHに保持するのが望ましい。The PLL of the reaction is carried out in the range of 5.0 to 8.5, but if the pH changes during the hydrolysis reaction, it is desirable to maintain the pH at the optimum level with an appropriate acid or alkaline aqueous solution.
反応において微生物あるいは酵素を水不溶性の一担体等
で固定化して、くり返し用いる事もできる。In the reaction, microorganisms or enzymes can be immobilized on a water-insoluble carrier and used repeatedly.
微生物の固定化は、例えばアクリルアミドポリマー、ウ
レタンポリマー、エチレングリコール誘導体ポリマー、
カラギーナン、アルギン酸カルシウム等による方法が挙
げられる。また酵素の固定化にはアンバーライトXAD
−7、アンバーライトXAD−2、ダイヤイオンHP2
0、ダイヤイオンHP2MG、オクチル・セファロース
0L−4B等の合成吸着剤等による方法等が挙げられる
。For immobilization of microorganisms, for example, acrylamide polymer, urethane polymer, ethylene glycol derivative polymer,
Examples include methods using carrageenan, calcium alginate, and the like. In addition, Amberlite XAD is used to immobilize enzymes.
-7, Amberlight XAD-2, Diaion HP2
Examples include methods using synthetic adsorbents such as 0, Diaion HP2MG, and Octyl Sepharose 0L-4B.
基質の〔I〕は水に対する溶解度は一般に低いが、撹拌
を充分すれば本反応にとって支障とならない。Substrate [I] generally has a low solubility in water, but this does not interfere with the reaction as long as it is sufficiently stirred.
しかし、反応をすみやかに進行させる目的でアセトン、
エタノール等の親水性溶媒や界面活性剤等を反応に支障
を与えない程度加えても良い。However, in order to speed up the reaction, acetone,
Hydrophilic solvents such as ethanol, surfactants, etc. may be added to the extent that they do not interfere with the reaction.
反応の追跡は、加水分解によって生成する有機酸をガス
クロマトグラフィーで分析し、添加した〔N〕の0.5
当量の有機酸が生成した時点で反応を終了させれば良い
。The reaction was monitored by analyzing the organic acid produced by hydrolysis using gas chromatography, and using 0.5 of the [N] added.
The reaction may be terminated when an equivalent amount of organic acid is produced.
加水分解物〔1〕と残存する〔I′〕を分離する方法と
しては、疎水性の有機溶剤、例えばヘキサン。As a method for separating the hydrolyzate [1] and the remaining [I'], a hydrophobic organic solvent such as hexane is used.
シクロヘキサン、石油エーテル、塩化メチレン。Cyclohexane, petroleum ether, methylene chloride.
クロロホルム、四塩化炭素等を用い、pll4.0〜8
.5の範囲に調整した反応液より、〔白のみあるいは若
干[11を含む〔1′〕を抽出分離し、必要あればシリ
カゲルクロマトグラフィー(ヘキサン−アセトン溶剤で
分離)にて〔1′〕と[11を分離し、各々純粋なもの
を得ることができる。更に反応液中に残存する〔置〕は
反応液のpHをNaOH等で9〜14にmWした後、前
記の溶剤で抽出すれば完全に回収することができる。こ
こで注意すべき事は、〔白はアルカリ条件で加水分解を
受けるため、最初からアルカリ性条件で(13と〔1′
〕を抽出することは、[13の光学純度低下をもたらす
ため良くない点である。Using chloroform, carbon tetrachloride, etc., pll4.0-8
.. From the reaction solution adjusted to the range of 5, [1'] containing only white or some [11] is extracted and separated, and if necessary, [1'] and [1'] are separated by silica gel chromatography (separated with hexane-acetone solvent). 11 can be separated to obtain pure products. Furthermore, the residue remaining in the reaction solution can be completely recovered by adjusting the pH of the reaction solution to 9-14 mW with NaOH or the like, and then extracting with the above-mentioned solvent. What should be noted here is that [white] undergoes hydrolysis under alkaline conditions, so it is necessary to start with alkaline conditions (13 and [1').
] is not good because it causes a decrease in the optical purity of [13].
〔白と〔璽〕との分離は、前記のシリカゲルクロマトグ
ラフィーでも、他の無機吸着剤、例えばフロリジル、ア
ルミナ、ゼオライト等、あるいは合成吸着剤、例えばア
ンバーライトXAD−7、アンバーライトXAD−2、
ダイヤイオンI−[P 20、ダイヤイオンFIP2M
G、オクチル−セファロース0L−4B等を用いて分!
Jすることもできる。[Separation of white and [Seal] can be carried out using the above-mentioned silica gel chromatography, other inorganic adsorbents such as Florisil, alumina, zeolite, etc., or synthetic adsorbents such as Amberlite XAD-7, Amberlite XAD-2,
Diamond Ion I-[P 20, Diamond Ion FIP2M
G, minutes using Octyl-Sepharose 0L-4B, etc.!
You can also do J.
炭素鎖の長い〔白と1口であれば蒸留によっても分離す
ることができる。If it has a long carbon chain (white), it can be separated by distillation.
光学活性なしI′道よ、そのまま合成原料として用いる
こともできるが、N aOH、KOH、Ca (OH)
2等のアルカリにより化学的に、あるいは立体選択性の
異なるエステラーゼや微生物を用いて加水分解すること
で容易に光学活性を保持したまま〔II〕に導くことも
できる。Since it has no optical activity, it can be used as a raw material for synthesis, but NaOH, KOH, Ca (OH)
It is also possible to easily lead to [II] while retaining the optical activity by chemically hydrolyzing it with an alkali such as No. 2, or using an esterase or microorganism with different stereoselectivity.
[11および〔白の光学純度の測定は次の方法で行なう
事ができる。〔白は前記の方法で加水分解後、〔I〕と
なし、〔II〕を塩化メチレン中、等モルのp−トルエ
ンスルホニルクロライドと反応させてトシル化後、これ
を高速液体クロマトグラフィー(f(I’T、C)(カ
ラム:キラルセルOB(日本分光製)φ0.46 X
25CrIt1溶出液 ヘキサン:イソプロパ/−ル(
20: 1 )、流速1.5 ml/min、 検出
221 nrn 、保持時間(R)体:36.7分、(
S)体 51.3分)により測定することができる。The optical purity of [11 and [white] can be measured by the following method. [The white color was hydrolyzed by the above method and converted to [I]. [II] was reacted with an equimolar amount of p-toluenesulfonyl chloride in methylene chloride to tosylate, and then subjected to high performance liquid chromatography (f( I'T, C) (Column: Chiral Cell OB (manufactured by JASCO Corporation) φ0.46
25CrIt1 eluent Hexane:isopropyl/-
20: 1), flow rate 1.5 ml/min, detection 221 nrn, retention time (R) body: 36.7 min, (
S) body 51.3 minutes).
(実施例)
以下、本発明を実施例により具体的に説明するが、本発
明はこれら実施例のみに限定されるものではない。(Examples) Hereinafter, the present invention will be specifically explained with reference to Examples, but the present invention is not limited only to these Examples.
実施例1
100mJの0,1Mリン酸緩衝液(pH7,’0 )
にリボプロティンリパーゼ(LPLアマノ3、シュード
モナス属由来、大野製薬■製)を0.1y及びラセミ体
の(R8)−N−ベンジル−3−ブチリルオキシピロリ
ジン10.9を添加し、塩酸でpH7、0に調整後、撹
拌下40℃で28時間反応を行ツタ。反応液をl 00
m!!のヘキサンで3回抽出し、減圧下で脱溶剤後、
油状の(8) −N−ベンジル−3−ブチリルオキシピ
ロリジン 4.95.9を得た。次に抽出残液をN a
OH溶液でpH13となし、各100m1!のヘキサン
で3回抽出し、減圧にて脱溶剤後、油状の(R)−N−
ベンジル−8−ヒドロキシピロリジン 8.42Iiを
得た。(8)−N−ベンジル−3−ブチリルオキシピロ
リジンを減圧上蒸留(182〜187℃7ammHy)
I、、4.5yの無色透明な精製品を得た。このものの
比旋光度はC(2〕719.2°(C;5、MeOH)
を示すと共に、NMRおよびIR,スペクトルは標品と
一致し、元素分析値は計算値と一致した。Example 1 100 mJ of 0.1M phosphate buffer (pH 7,'0)
To the solution, 0.1y of riboprotein lipase (LPL Amano 3, derived from Pseudomonas sp., manufactured by Ohno Pharmaceutical Co., Ltd.) and 10.9% of racemic (R8)-N-benzyl-3-butyryloxypyrrolidine were added, and the pH was adjusted to 7 with hydrochloric acid. After adjusting the temperature to 0, the reaction was carried out at 40°C for 28 hours with stirring. The reaction solution is 1 00
m! ! After extracting with hexane three times and removing the solvent under reduced pressure,
Oily (8)-N-benzyl-3-butyryloxypyrrolidine 4.95.9 was obtained. Next, the extraction residue was Na
Adjust the pH to 13 with OH solution, 100ml each! After extracting three times with hexane and removing the solvent under reduced pressure, the oily (R)-N-
Benzyl-8-hydroxypyrrolidine 8.42Ii was obtained. (8) Distillation of -N-benzyl-3-butyryloxypyrrolidine under reduced pressure (182-187°C 7amHy)
A colorless and transparent purified product of I, 4.5y was obtained. The specific optical rotation of this product is C (2) 719.2° (C; 5, MeOH)
The NMR, IR, and spectra were consistent with the standard, and the elemental analysis values were consistent with the calculated values.
次に、水晶にI N−Na0TI 50ml!を加え
、加熱下、加水分解を行ない、塩化メチレン50m1!
にて3回抽出した。これを減圧上脱溶剤を行ない、84
1gの(8) −N−ベンジル−3−ヒドロキシピロリ
ジンを得た。これを減圧上蒸留しく111℃/ 2 ’
mmH5t ) 、無色油状物を3.00,9得た。こ
のもののNMRおよび1几スペクトルは標品と一致し、
元素分析値は計算値とよく一致した。比旋光度は〔α]
−8,79°(C=5、MeOH)を示した。高
速液体クロマトグラフィーでの測定による光学純度は1
00%e、e、であった。一方、(R)−N−ベンジル
−3−ヒドロキシピロリジンの蒸留後の比旋光度は(a
〕+8.73゜(C=5、MeOH)、光学純度は99
%e、 e、であった。Next, add 50ml of IN-Na0TI to the crystal! was added and hydrolyzed under heating to produce 50ml of methylene chloride!
Extracted three times. The solvent was removed under reduced pressure, and 84
1 g of (8)-N-benzyl-3-hydroxypyrrolidine was obtained. This was distilled under reduced pressure at 111℃/2'
mmH5t), 3.00.9% of a colorless oil was obtained. The NMR and 1-liter spectrum of this product match the standard product,
The elemental analysis values were in good agreement with the calculated values. Specific rotation is [α]
−8.79° (C=5, MeOH). Optical purity measured by high performance liquid chromatography is 1
It was 00% e, e. On the other hand, the specific optical rotation of (R)-N-benzyl-3-hydroxypyrrolidine after distillation is (a
] +8.73° (C=5, MeOH), optical purity is 99
%e, e.
実施例2〜14
100mJの0.1 M−リン酸緩衝液(p I−I
7.0)にラセミ体の(IL8)−N−ベンジル−3−
アシロキシピロリジンを各45.5Eリモル添加し、更
にリポプロティンリパーゼ(LPL アマノ3)を0
.1〜1.Oy添加し、塩酸でp■を7.0に調整後、
撹拌下40℃で24〜72時間反応を行った。添加基質
の50πが加水分解された時点で反応を止め、塩化メチ
レン100rn/で5回抽出を行ない、未反応の(8)
−N−ベンジル−3−アシロキシピロリジンと、加水
分解された(R)−N−ベンジル−3−ヒドロキシピロ
リジンとの混合物を得た。Examples 2-14 100 mJ of 0.1 M phosphate buffer (p I-I
7.0) with racemic (IL8)-N-benzyl-3-
Add 45.5 E mol each of acyloxypyrrolidine, and further add 0 ml of lipoprotein lipase (LPL Amano 3).
.. 1-1. After adding Oy and adjusting p■ to 7.0 with hydrochloric acid,
The reaction was carried out at 40° C. for 24 to 72 hours with stirring. The reaction was stopped when 50π of the added substrate was hydrolyzed, and the unreacted (8) was extracted 5 times with 100rn/methylene chloride.
A mixture of -N-benzyl-3-acyloxypyrrolidine and hydrolyzed (R)-N-benzyl-3-hydroxypyrrolidine was obtained.
減圧上脱溶剤を行なったのち、シリカゲルカラム(ワコ
ーC200,2ooy)に負荷し、ヘキサン−酢酸エチ
ル(10:2〜5 : 10)で溶出分it、、(S)
−N−ベンジル−3−アシロキシピロリジンと(R)
−N−ベンジル−3−ヒドロキシピロリジン各々を得た
。(S) −N−ベンジル−3−アシロキシピロリジン
は実厖例1と同様に加水分解した後、光学純度を測定し
た。これらの結果を表1に示す。After removing the solvent under reduced pressure, it was loaded onto a silica gel column (Wako C200, 2ooy) and eluted with hexane-ethyl acetate (10:2 to 5:10).
-N-benzyl-3-acyloxypyrrolidine and (R)
-N-benzyl-3-hydroxypyrrolidine was obtained. (S)-N-benzyl-3-acyloxypyrrolidine was hydrolyzed in the same manner as in Example 1, and then its optical purity was measured. These results are shown in Table 1.
実施例15
リポプロティンリパーゼ(T、 P T、アマノ3)2
yを0.05M−リン酸緩衝液(pH7,0)40me
に懸濁し、これにアンバーライトXAD−7を40.9
添加し、−夜撹拌し、酵素を樹脂に吸着させた。次に樹
脂を濾過後、約500m/の0.05M−リン酸緩衝液
(pH7,0)で洗浄し、未吸着の酵素を除去した。こ
の酵素吸着樹脂をカラム(φ2,2x15cm)につめ
、33℃に保温しながら(RS’)−N−ベンジル−3
−ヘキサノイルオキシピロリジン5gを負荷した。次に
0.05M−リン酸緩衝液(p )I 7.0 )を5
oOm、ff流し、(R)−N−ベンジル−3−ヒドロ
キシピロリジンを溶出した。次にヘキサンを500 m
l流し、未反応の(8) −N−ベンジル−3−ヘキサ
ノイルオキシピロリジンを溶出した。Example 15 Lipoprotein lipase (T, PT, Amano 3) 2
y in 0.05M phosphate buffer (pH 7,0) 40me
Amberlite XAD-7 was suspended at 40.9
The enzyme was adsorbed onto the resin by stirring overnight. Next, the resin was filtered and washed with about 500 m/m of 0.05M phosphate buffer (pH 7.0) to remove unadsorbed enzyme. This enzyme adsorption resin was packed in a column (φ2, 2 x 15 cm), and while keeping it at 33℃, (RS')-N-benzyl-3
- Loaded with 5 g of hexanoyloxypyrrolidine. Next, add 0.05M phosphate buffer (p)I 7.0) to
oOm and ff were run to elute (R)-N-benzyl-3-hydroxypyrrolidine. Then add 500 m of hexane
unreacted (8)-N-benzyl-3-hexanoyloxypyrrolidine was eluted.
(R)−N−ベンジル−3−ヒドロキシピロリジンを含
む溶液を減圧濃縮して50mJとし、NaOHでprt
tsとした後、100m!!の塩化メチレンで3回抽出
した。減圧上脱溶剤後、減圧蒸留して無色油状の(R)
−N−ベンジル−3−ヒドロキシピロリジン1.32.
Fを得た。このものの比旋光度は〔α〕+3.75°(
C=5、MeOH)を示し、HP L C分析による光
学純度は99πe、 e、であった。The solution containing (R)-N-benzyl-3-hydroxypyrrolidine was concentrated under reduced pressure to 50 mJ, and NaOH was added to prt.
After ts, 100m! ! of methylene chloride three times. After removing the solvent under reduced pressure, it was distilled under reduced pressure to obtain (R) as a colorless oil.
-N-benzyl-3-hydroxypyrrolidine 1.32.
I got an F. The specific optical rotation of this object is [α] + 3.75° (
C=5, MeOH), and the optical purity by HPLC analysis was 99πe, e.
一方、(8’)−N−ベンジル−3−ヘキサノイルオキ
シピロリジンは、ヘキサンを減圧上脱溶剤した後、減圧
蒸留(bl)、160℃/ 8 mmHji )にて精
製し、無色油状で2.21.V得た。このものの比旋光
度はCαl −15,8°(C=5、MeO[()
を示しtこ。更にアルカリ条件で加水分解をし、(8)
−N−−ベンジル−3−ヒドロキシピロリジンとなし
、これをトシル化後、)[PLCで光学純度を測定した
ところ100πe、e、であった。On the other hand, (8')-N-benzyl-3-hexanoyloxypyrrolidine was purified by distillation under reduced pressure (BL) at 160°C/8 mmHji) after removing the solvent from hexane under reduced pressure. 21. I got V. The specific optical rotation of this material is Cαl −15,8° (C=5, MeO[()
Show this. Further hydrolysis under alkaline conditions (8)
-N--benzyl-3-hydroxypyrrolidine, which was tosylated) [The optical purity was measured by PLC and found to be 100πe, e.
実施例16〜22
グルコース2π、イーストエキス0,5π、肉エキス0
,3%、ペプトン0.3%、オリーブ油1%(pH7,
0)の組成からなる栄養液体借地1500rr+/を8
1容ミニジヤーに入れ、120℃、20分間殺菌後、表
2に示す微生物を植菌し、30℃、40時間通気1vv
m、撹拌500 rpmで培養した。その後p■【を7
.0に調整し、(R8)−N−ベンジル−3−ヘキサノ
イルオキシピロリジン5yを添加し、30℃で48時間
反応させた。反応後、遠心分離して菌体を除去し、上清
を等量のヘキサンで3回抽出し、未反応のN−ベンジル
−3−ヘキサノイルオキシピロリジンを回収した。Examples 16-22 Glucose 2π, yeast extract 0.5π, meat extract 0
, 3%, peptone 0.3%, olive oil 1% (pH 7,
0) Nutrient liquid 1500rr +/- consisting of the composition of 8
Place in a 1 volume mini jar, sterilize at 120°C for 20 minutes, inoculate with the microorganisms shown in Table 2, and incubate at 30°C for 40 hours with 1vv aeration.
m, stirring at 500 rpm. Then p■ [7
.. 0, (R8)-N-benzyl-3-hexanoyloxypyrrolidine 5y was added, and the mixture was reacted at 30°C for 48 hours. After the reaction, the bacterial cells were removed by centrifugation, and the supernatant was extracted three times with equal amounts of hexane to recover unreacted N-benzyl-3-hexanoyloxypyrrolidine.
次に抽出残液をNaOH溶液でpI(18とし、等量の
塩化メチレンで3回抽出し、加水分解されたN−ベンジ
ル−3−ヒドロキシピロリジンを得た。Next, the extraction residue was adjusted to pI (18) with NaOH solution and extracted three times with an equal amount of methylene chloride to obtain hydrolyzed N-benzyl-3-hydroxypyrrolidine.
減圧上脱溶剤の後、蒸留により無色透明のN−ベンジル
−3−ヒドロキシピロリジンを得、これをトシル化後、
HPLOによる光学純度を測定した結果表2の如くであ
った。After removing the solvent under reduced pressure, clear colorless N-benzyl-3-hydroxypyrrolidine was obtained by distillation, and after tosylation,
The optical purity was measured by HPLO and the results were as shown in Table 2.
表 2
実施例23〜28
100rRの0.1 Mリン酸緩衝液(pH7,0)に
(R8)−N−ベンジル−3−ヘキサノイルオキシピロ
リジン10.9を添加し、更に表3に示す市販酵素を添
加し、40℃、撹拌下22〜120時間反応を行った。Table 2 Examples 23 to 28 10.9 of (R8)-N-benzyl-3-hexanoyloxypyrrolidine was added to 100 rR of 0.1 M phosphate buffer (pH 7,0), and the commercially available compounds shown in Table 3 were added. The enzyme was added and the reaction was carried out at 40° C. for 22 to 120 hours with stirring.
反応液を等量のヘキサンで3回抽出し、未反応のN−ベ
ンジル−3−ヘキサノイルオキシピロリジンを回収した
。その後Na0FI溶液でpHを13とし、等量の塩化
メチレンで3回抽出し、加水分解されたN−ベンジル−
3−ヒドロキシピロリジンを抽出分離した。減圧上脱溶
剤を行ない、次に蒸留に、より精製して無色透明油状の
N−ベンジル−3−ヒドロキシピロリジンを得た。これ
をトシル化後、HPLCにより光学純度を測定した結果
を表3に示す。The reaction solution was extracted three times with equal amounts of hexane to recover unreacted N-benzyl-3-hexanoyloxypyrrolidine. The pH was then adjusted to 13 with Na0FI solution, extracted three times with an equal volume of methylene chloride, and the hydrolyzed N-benzyl-
3-Hydroxypyrrolidine was extracted and separated. The solvent was removed under reduced pressure and then purified by distillation to obtain N-benzyl-3-hydroxypyrrolidine as a colorless transparent oil. After tosylating this, the optical purity was measured by HPLC and the results are shown in Table 3.
表 3Table 3
Claims (9)
置換アルキル基、アルケニル基を示す。〕で示される(
R)および(S)−N−ベンジル−3−アシロキシピロ
リジン混合物を立体選択的に加水分解して、一般式〔I
I〕▲数式、化学式、表等があります▼〔II〕で示され
る光学活性なN−ベンジル−3−ヒドロキシピロリジン
を生成させる立体選択的エステラーゼ活性を有する微生
物あるいは酵素を一般式〔 I 〕で示される(R)およ
び(S)−N−ベンジル−3−アシロキシピロリジン混
合物に作用させ、光学活性なN−ベンジル−3−ヒドロ
キシピロリジン〔II〕と、これと立体的に対掌な一般式
〔 I ′〕 ▲数式、化学式、表等があります▼〔 I ′〕 (式中、Xは前記と同じ)で示される光学 活性なN−ベンジル−3−アシロキシピロリジンとに光
学分割し、夫々の光学活性化合物を分離採取することを
特徴とする光学活性なN−ベンジル−3−ヒドロキシピ
ロリジン及び/またはその対掌体の光学活性N−ベンジ
ル−3−アシロキシピロリジンの製造法。(1) General formula [I] ▲ Numerical formulas, chemical formulas, tables, etc. are available▼ [I] [In the formula, X represents hydrogen, a substituted or unsubstituted alkyl group having 1 to 17 carbon atoms, or an alkenyl group. ] Indicated by (
R) and (S)-N-benzyl-3-acyloxypyrrolidine mixture was stereoselectively hydrolyzed to form the general formula [I
I]▲There are mathematical formulas, chemical formulas, tables, etc.▼The microorganism or enzyme having stereoselective esterase activity that produces optically active N-benzyl-3-hydroxypyrrolidine shown in [II] is shown by the general formula [I]. (R) and (S)-N-benzyl-3-acyloxypyrrolidine mixture to form optically active N-benzyl-3-hydroxypyrrolidine [II] and the sterically opposite general formula [II]. I'] ▲There are mathematical formulas, chemical formulas, tables, etc.▼[I'] (In the formula, X is the same as above) A method for producing optically active N-benzyl-3-hydroxypyrrolidine and/or its enantiomer optically active N-benzyl-3-acyloxypyrrolidine, which comprises separating and collecting an optically active compound.
ロキシピロリジンであり、一般式〔I′〕の化合物が(
S)−〔I′〕 ▲数式、化学式、表等があります▼(S)−〔 I ′〕 (Xは前記と同じ)で示される光学活性(S)−N−ベ
ンジル−3−アシロキシピロリジンである特許請求の範
囲第1項記載の製造法。(2) Compound [II] has the optical activity (R)-N-benzyl-3-hydroxy represented by the formula (R)-[II] ▲There are mathematical formulas, chemical formulas, tables, etc.▼(R)-[II] pyrrolidine, and the compound of general formula [I'] is (
S)-[I'] ▲There are mathematical formulas, chemical formulas, tables, etc.▼(S)-[I'] (X is the same as above) Optically active (S)-N-benzyl-3-acyloxypyrrolidine The manufacturing method according to claim 1.
いは酵素が、シュードモナス属、ムコール属、アルカリ
ゲネス属に属する微生物、あるいは該微生物由来の酵素
である特許請求の範囲第1項または第2項記載の製造法
。(3) The production method according to claim 1 or 2, wherein the microorganism or enzyme having stereoselective esterase activity is a microorganism belonging to the genus Pseudomonas, Mucor, or Alcaligenes, or an enzyme derived from the microorganism. .
ロキシピロリジンであり、一般式〔 I ′〕の化合物が
(R)−〔 I ′〕 ▲数式、化学式、表等があります▼(R)−〔 I ′〕 (Xは前記と同じ)で示される光学活性 (R)−N−ベンジル−3−アシロキシピロリジンであ
る特許請求の範囲第1項記載の製造法。(4) Compound [II] is an optically active (S)-N-benzyl-3-hydroxypyrrolidine represented by the formula (S)-[II] ▲There are mathematical formulas, chemical formulas, tables, etc.▼(S)-[II] The compound with the general formula [I ′] has the optical activity represented by (R)-[I ′] ▲There are mathematical formulas, chemical formulas, tables, etc.▼(R)-[I ′] (X is the same as above) The method for producing (R)-N-benzyl-3-acyloxypyrrolidine according to claim 1.
いは、酵素がリゾップス属、フイコマイセス属に属する
微生物、あるいは該微生物由来の酵素である特許請求の
範囲第1項または第4項記載の製造法。(5) The production method according to claim 1 or 4, wherein the microorganism having stereoselective esterase activity or the enzyme is a microorganism belonging to the genus Rhizopus or the genus Fucomyces, or an enzyme derived from the microorganism.
し第5項いずれかの項記載の製造法。(6) The production method according to any one of claims 1 to 5, wherein the enzyme is lipase.
いは酵素を水不溶性担体に固定化して用いる特許請求の
範囲第1項ないし第6項いずれかの項記載の製造法。(7) The production method according to any one of claims 1 to 6, in which a microorganism or enzyme having stereoselective esterase activity is immobilized on a water-insoluble carrier.
N−ベンジル−3−アシロキシピロリジン混合物を微生
物あるいは酵素により立体選択的に加水分解をして得ら
れる光学活性なN−ベンジル−3−ヒドロキシピロリジ
ン〔II〕と光学活性なN−ベンジル−3−アシロキシピ
ロリジン〔 I ′〕との混合物から〔II〕と〔 I ′〕と
を分離採取する際に、無機吸着剤あるいは合成吸着剤を
担体とするカラムクロマトグラフィーにより分離し、夫
々を採取することを特徴とする特許請求の範囲第1項な
いし第7項いずれかの項記載の製造法。(8) (R) and (S)- represented by the general formula [I]
Optically active N-benzyl-3-hydroxypyrrolidine [II] obtained by stereoselectively hydrolyzing an N-benzyl-3-acyloxypyrrolidine mixture with a microorganism or enzyme and optically active N-benzyl-3- When separating and collecting [II] and [I'] from a mixture with acyloxypyrrolidine [I'], separate them by column chromatography using an inorganic or synthetic adsorbent as a carrier, and collect each. A manufacturing method according to any one of claims 1 to 7, characterized in that:
N−ベンジル−3−アシロキシピロリジン混合物を微生
物あるいは酵素により立体選択的に加水分解をして得ら
れる光学活性なN−ベンジル−3−ヒドロキシピロリジ
ン〔II〕と光学活性なN−ベンジル−3−アシロキシピ
ロリジン〔 I ′〕との混合物から〔II〕と〔 I ′〕と
を分離採取する際に、疎水性溶剤を用いて〔 I ′〕を
抽出して〔II〕と分離し、夫々を採取することを特徴と
する特許請求の範囲第1項ないし第7項いずれかの項記
載の製造法。(9) (R) and (S)- represented by the general formula [I]
Optically active N-benzyl-3-hydroxypyrrolidine [II] obtained by stereoselectively hydrolyzing an N-benzyl-3-acyloxypyrrolidine mixture with a microorganism or enzyme and optically active N-benzyl-3- When [II] and [I ′] are separated and collected from a mixture with acyloxypyrrolidine [I ′], [I ′] is extracted using a hydrophobic solvent and separated from [II], and each is separated from [II]. 8. A manufacturing method according to any one of claims 1 to 7, characterized in that the product is collected.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30105287A JP2703768B2 (en) | 1987-11-28 | 1987-11-28 | Method for producing optically active 3-hydroxypyrrolidine derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30105287A JP2703768B2 (en) | 1987-11-28 | 1987-11-28 | Method for producing optically active 3-hydroxypyrrolidine derivative |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13110097A Division JP2813342B2 (en) | 1997-05-21 | 1997-05-21 | Method for producing optically active 3-hydroxypyrrolidine derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01141600A true JPH01141600A (en) | 1989-06-02 |
JP2703768B2 JP2703768B2 (en) | 1998-01-26 |
Family
ID=17892282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP30105287A Expired - Lifetime JP2703768B2 (en) | 1987-11-28 | 1987-11-28 | Method for producing optically active 3-hydroxypyrrolidine derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2703768B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5187094A (en) * | 1989-09-06 | 1993-02-16 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Method for the preparation of optically active 3-hydroxypyrrolidine derivatives |
EP0692471A1 (en) | 1994-07-15 | 1996-01-17 | Degussa Aktiengesellschaft | Process for the preparation of optically active 3-hydroxypyrrolidine derivatives with high optical purity |
US6613550B2 (en) | 2000-02-29 | 2003-09-02 | Pfizer Inc. | Microbial process for preparation of optically active 3-hydroxypyrrolidine derivatives |
WO2007024113A1 (en) | 2005-08-25 | 2007-03-01 | Rstech Corporation | Process for the preparation of chiral 3-hydroxy pyrrolidine compound and derivatives thereof having high optical purity |
WO2010058429A1 (en) | 2008-11-24 | 2010-05-27 | Council Of Scientific & Industrial Research | A process for the preparation of optically active n-benzyl-3 hydroxypyrrolidines |
-
1987
- 1987-11-28 JP JP30105287A patent/JP2703768B2/en not_active Expired - Lifetime
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5187094A (en) * | 1989-09-06 | 1993-02-16 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Method for the preparation of optically active 3-hydroxypyrrolidine derivatives |
EP0692471A1 (en) | 1994-07-15 | 1996-01-17 | Degussa Aktiengesellschaft | Process for the preparation of optically active 3-hydroxypyrrolidine derivatives with high optical purity |
US6613550B2 (en) | 2000-02-29 | 2003-09-02 | Pfizer Inc. | Microbial process for preparation of optically active 3-hydroxypyrrolidine derivatives |
WO2007024113A1 (en) | 2005-08-25 | 2007-03-01 | Rstech Corporation | Process for the preparation of chiral 3-hydroxy pyrrolidine compound and derivatives thereof having high optical purity |
WO2010058429A1 (en) | 2008-11-24 | 2010-05-27 | Council Of Scientific & Industrial Research | A process for the preparation of optically active n-benzyl-3 hydroxypyrrolidines |
US8445700B2 (en) | 2008-11-24 | 2013-05-21 | Council Of Scientific & Industrial Research | Process for the preparation of optically active N-benzyl-3 hydroxypyrrolidines |
Also Published As
Publication number | Publication date |
---|---|
JP2703768B2 (en) | 1998-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS63273499A (en) | Production of optically active compound | |
CA2600436A1 (en) | Enzymatic transformation of a prostaglandin (bimatoprost) intermediate | |
US4745066A (en) | Method for producing optically active glycol derivatives | |
JPH01141600A (en) | Production of optically active 3-hydroxypyrrolidine derivative | |
JPS63284184A (en) | Optically active compound and production thereof | |
US5187094A (en) | Method for the preparation of optically active 3-hydroxypyrrolidine derivatives | |
KR20040054842A (en) | Method for preparing an (R)- or (S)- form of N-(2,6-dimethyl phenyl) alanine and a counter enantiomeric form of N-(2,6-dimethyl phenyl) alanine ester thereto using enzyme | |
Miyazawa et al. | Resolution of racemic carboxylic acids via the lipase‐catalyzed irreversible transesterification of vinyl esters | |
WO2004003001A1 (en) | Process for the enzymatic resolution of 1,3-dioxolane-4-carboxylates | |
EP0512848B1 (en) | Enzymatic resolution of alpha-tertiary carboxylic acid esters | |
US4865771A (en) | Process for preparing L(-)-carnitine chloride from 3,4-epoxybutyric esters and novel intermediate compounds | |
US4863859A (en) | Process for preparing optically active glycerol derivatives | |
JP2813342B2 (en) | Method for producing optically active 3-hydroxypyrrolidine derivative | |
EP0474250A2 (en) | Enzymatic process for separating the optical isomers of racemic 1,2-diols | |
US4985366A (en) | Process for the enzymatic resolution of the optical isomers of racemic ester derivatives of 3-mercapto-2-alkyl-propionic acid | |
JP3732535B2 (en) | Process for producing optically active α-methylalkanedicarboxylic acid-ω-monoester and its enantiomer diester | |
JP2003534808A (en) | Method for preparing R- or S-form α-substituted heterocyclic carboxylic acid and enantiomer α-substituted heterocyclic carboxylate using an enzyme | |
WO1993022451A1 (en) | PROCESS OF PREPARING ENRICHED ENANTIOMERS OF GLYCEROL CARBONATE AND DERIVATIVES THEREOF FOR SYNTHESIS OF β-BLOCKERS | |
US5702928A (en) | Process for producing optically active triazole compounds and method of racemizing optically active triazole compounds | |
EP0869185B9 (en) | Production of optically active sphingoid compound | |
Kamal et al. | Lipase-catalyzed resolution of 1-chloro-3-[(4-morpholin-4-yl-1, 2, 5-thiadiazole-3-yl) oxy] propan-2-ol: Synthesis of (R)-and (S)-timolol | |
JPH01281098A (en) | Production of optically active carboxylic acid and optically active carboxylic acid ester | |
JPH0533995B2 (en) | ||
JPH02104295A (en) | Production of optically active amine and its derivative | |
JPH0573396B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071003 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081003 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081003 Year of fee payment: 11 |